Should patients with active urological cancers receive thromboprophylaxis for Cancer Associated Thrombosis (CAT)?

Authors :: N.G. Tsoukalas
V. Barbounis
S. Demiri
N. Ziras
I. Sgouros
A. Christopoulou
Georgios Samelis
Achilleas Nikolakopoulos
Alexandros Bokas
P. Papakostas
Ilias Athanasiadis
Gerasimos Aravantinos
Stavros D. Peroukidis
N. Kapodistrias
A. Psyrri
G. Papatsimpas
I. Boukovinas
N. Kentepozidis
Anna Koumarianou
E. Timotheadou
D. Mavroudis
Alexandros Ardavanis
Christos Papandreou
C. Andreadis
P. Papakotoulas
Source :: European Urology Open Science. 33:S417-S418
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
Internal medicine
medicine
Cancer associated thrombosis
business
Urological cancers

Tools